Aquatic Capital Management’s Stoke Therapeutics STOK Stock Holding History

Aquatic Capital Management’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506K	Buy	+15,471	New	+$497K	0.02%	788
2025 Q3	–	Sell	-11,099	Closed	-$126K	–	1657
2025 Q2	$126K	Sell	11,099 -12,544	-53%	-$119K	﹤0.01%	1067
2025 Q1	$157K	Buy	+23,643	New	+$220K	﹤0.01%	989
2024 Q2	–	Sell	-9,600	Closed	-$130K	–	1580
2024 Q1	$130K	Buy	+9,600	New	+$58.2K	﹤0.01%	860
2023 Q1	–	Sell	-100	Closed	-$1K	–	1733
2022 Q4	$1K	Sell	100 -7,600	-99%	-$79K	﹤0.01%	1292
2022 Q3	$99K	Buy	7,700 +5,700	+285%	+$90.8K	0.01%	757
2022 Q2	$26K	Buy	2,000 +800	+67%	+$12.2K	0.01%	792
2022 Q1	$25K	Sell	1,200 -100	-8%	-$2K	0.04%	445
2021 Q4	$31K	Buy	+1,300	New	+$31K	0.06%	464

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Aquatic Capital Management's STOK Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 15,471 shares worth $506K. The stake represents 0.02% of the portfolio and ranks #788 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in STOK as recently as Q2 2025.

Aquatic Capital Management first reported a position in STOK in Q4 2021 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Aquatic Capital Management held 15,471 shares of Stoke Therapeutics worth $506K as of Q2 2026.
Stoke Therapeutics was a new Aquatic Capital Management position in Q2 2026.
Stoke Therapeutics made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #788 holding.
Aquatic Capital Management first reported a position in Stoke Therapeutics in Q4 2021 and has held it in 9 quarters since.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.